Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention-Reference-Cited by-同舟云学术

Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention

Published:2010-12 Issue:6 Volume:160 Page:1170-1177
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Marenzi Giancarlo,De Metrio Monica,Rubino Mara,Lauri Gianfranco,Cavallero Annalisa,Assanelli Emilio,Grazi Marco,Moltrasio Marco,Marana Ivana,Campodonico Jeness,Discacciati Andrea,Veglia Fabrizio,Bartorelli Antonio L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials;Keeley;Lancet,2003

2. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction;Marenzi;J Am Coll Cardiol,2004

3. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality;Marenzi;Ann Intern Med,2009

4. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction;Oswald;BMJ,1986

5. Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes;Oswald;Diabet Med,1987

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity is associated with acute kidney injury in ST‐segment‐elevation myocardial infarction undergoing percutaneous coronary intervention: A national representative cohort study;Catheterization and Cardiovascular Interventions;2024-04-24

2. Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-03-11

3. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry;Diabetes Research and Clinical Practice;2023-08

4. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in Diabetic patients with Acute Myocardial Infarction: Insight from SGLT2-I AMI PROTECT Registry;2023-04-26

5. Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: A dose–response meta-analysis;Frontiers in Cardiovascular Medicine;2022-09-12